1. Disperati P, Ichim CV, Tkachuk D, Chune K, Schuh AC, Wells RA. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res. 2006;30:233–9.
2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
3. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88.
4. Park MJ, Kim HJ, Kim SH, Kim DH, Kim SJ, Jang JH, Kim K, Kim WS, Jung CW. Is international prognostic scoring system (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO classification-based prognostic scoring system (WPSS) and comparison with IPSS. Eur J Haematol. 2008;81(5):364–73.
5. Braun T, et al. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases. Leuk Res. 2011;35:863–7.